Intellia Therapeutics (NTLA) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free NTLA Stock Alerts $26.20 -0.02 (-0.08%) (As of 01:21 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Intellia Therapeutics Short Interest DataCurrent Short Interest15,440,000 sharesPrevious Short Interest14,590,000 sharesChange Vs. Previous Month+5.83%Dollar Volume Sold Short$330.42 millionShort Interest Ratio10.5 Days to CoverLast Record DateApril 30, 2024Outstanding Shares96,470,000 sharesPercentage of Shares Shorted16.00%Today's Trading Volume336,083 sharesAverage Trading Volume1,462,836 sharesToday's Volume Vs. Average23% Short Selling Intellia Therapeutics ? Sign up to receive the latest short interest report for Intellia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNTLA Short Interest Over TimeNTLA Days to Cover Over TimeNTLA Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Intellia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202415,440,000 shares $330.42 million +5.8%N/A10.5 $21.40 4/15/202414,590,000 shares $334.40 million -1.6%N/A9.5 $22.92 3/31/202414,830,000 shares $407.97 million +9.9%N/A9.6 $27.51 3/15/202413,500,000 shares $382.05 million +7.0%N/A8.6 $28.30 2/29/202412,620,000 shares $405.35 million +8.5%N/A7.6 $32.12 2/15/202411,630,000 shares $331.11 million +6.0%N/A7.5 $28.47 Get the Latest News and Ratings for NTLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202410,970,000 shares $261.31 million +5.0%N/A7.1 $23.82 1/15/202410,450,000 shares $289.15 million +2.9%N/A6.8 $27.67 12/31/202310,160,000 shares $309.78 million -3.2%N/A6.8 $30.49 12/15/202310,500,000 shares $323.19 million +6.6%N/A7.2 $30.78 11/30/20239,850,000 shares $291.86 million +4.0%N/A7.6 $29.63 11/15/20239,470,000 shares $251.71 million -1.7%N/A8 $26.58 10/31/20239,630,000 shares $241.23 million +18.6%N/A9.7 $25.05 10/15/20238,120,000 shares $242.22 million -1.1%N/A9.7 $29.83 9/30/20238,210,000 shares $259.60 million +6.2%N/A10.3 $31.62 9/15/20237,730,000 shares $276.89 million -1.4%N/A10 $35.82 8/31/20237,840,000 shares $293.84 million +7.5%N/A9.4 $37.48 8/15/20237,290,000 shares $282.92 million +13.9%N/A8.1 $38.81 7/31/20236,400,000 shares $270.91 million +3.1%N/A6.7 $42.33 7/15/20236,210,000 shares $272.99 million +2.5%N/A6.3 $43.96 6/30/20236,060,000 shares $247.13 million +5.4%N/A5.9 $40.78 6/15/20235,750,000 shares $262.03 million +9.7%N/A5.6 $45.57 5/31/20235,240,000 shares $195.24 million -11.8%N/A5 $37.26 5/15/20235,940,000 shares $271.81 million -13.0%N/A5.4 $45.76 4/30/20236,830,000 shares $257.83 million -2.0%N/A6.3 $37.75 4/15/20236,970,000 shares $265.98 million -6.1%N/A6.2 $38.16 3/31/20237,420,000 shares $276.54 million -5.8%N/A6.5 $37.27 3/15/20237,880,000 shares $322.13 million -2.7%N/A6.8 $40.88 2/28/20238,100,000 shares $325.38 million +6.6%N/A6.5 $40.17 2/15/20237,600,000 shares $317.53 million +3.4%N/A6.3 $41.78 1/31/20237,350,000 shares $311.93 million +12.0%N/A6.1 $42.44 1/15/20236,560,000 shares $246.92 million -1.1%N/A5.7 $37.64 12/30/20226,630,000 shares $231.32 million +11.4%N/A6 $34.89 12/15/20225,950,000 shares $217.35 million -1.2%N/A5.4 $36.53 11/30/20226,020,000 shares $309.79 million -9.5%N/A5.2 $51.46 11/15/20226,650,000 shares $351.92 million -5.1%N/A6.7 $52.92 10/31/20227,010,000 shares $369.99 million +6.5%N/A6.7 $52.78 10/15/20226,580,000 shares $344.59 million -4.2%N/A5.8 $52.37 9/30/20226,870,000 shares $384.45 million +2.8%N/A5.9 $55.96 9/15/20226,680,000 shares $458.11 million -2.8%N/A5.2 $68.58Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 8/31/20226,870,000 shares $412.61 million -1.4%N/A5.5 $60.06 8/15/20226,970,000 shares $476.89 million +3.4%10.2%5.4 $68.42 7/31/20226,740,000 shares $436.48 million -6.7%9.9%5 $64.76 7/15/20227,220,000 shares $456.88 million -3.5%10.6%5.6 $63.28 6/30/20227,480,000 shares $387.16 million +7.0%11.0%5.9 $51.76 6/15/20226,990,000 shares $286.10 million +5.4%10.3%5.9 $40.93 5/31/20226,630,000 shares $305.91 million -4.6%9.8%6.2 $46.14 5/15/20226,950,000 shares $337.77 million +11.4%10.2%5.8 $48.60 4/30/20226,240,000 shares $305.95 million +9.9%9.3%5.5 $49.03 4/15/20225,680,000 shares $340.40 million +1.1%8.5%5 $59.93 3/31/20225,620,000 shares $408.41 million +4.5%8.4%4.8 $72.67 3/15/20225,380,000 shares $313.49 million +1.5%8.0%4.8 $58.27 2/28/20225,300,000 shares $523.91 million +7.3%7.9%4.9 $98.85 2/15/20224,940,000 shares $486.69 million +2.9%7.4%5.2 $98.52 1/31/20224,800,000 shares $453.94 million +10.3%7.2%5.4 $94.57 1/15/20224,350,000 shares $397.46 million +1.9%6.5%5.4 $91.37 12/31/20214,270,000 shares $504.88 million -7.4%6.4%6 $118.24 12/15/20214,610,000 shares $563.80 million +16.1%6.9%6.2 $122.30 11/30/20213,970,000 shares $456.59 million +14.4%5.9%5.4 $115.01 11/15/20213,470,000 shares $463.38 million +4.8%5.2%4.6 $133.54 10/29/20213,310,000 shares $440.16 million -10.3%5.0%4.3 $132.98 10/15/20213,690,000 shares $481.51 million +5.7%5.6%4.1 $130.49 9/30/20213,490,000 shares $468.18 million -0.6%5.3%3.5 $134.15 9/15/20213,510,000 shares $528.04 million +2.3%5.3%1.7 $150.44 8/31/20213,430,000 shares $550.62 million -3.7%5.2%1.6 $160.53 8/13/20213,560,000 shares $553.19 million -2.2%5.4%1.6 $155.39 7/30/20213,640,000 shares $516.33 million +7.1%5.5%1.6 $141.85 7/15/20213,400,000 shares $469.54 million -26.6%5.2%1.5 $138.10 6/30/20214,630,000 shares $749.64 million -23.6%7.1%2.1 $161.91 6/15/20216,060,000 shares $537.22 million -7.3%10.1%4.7 $88.65 5/28/20216,540,000 shares $490.11 million -1.5%10.9%5.4 $74.94 5/14/20216,640,000 shares $404.24 million +0.5%N/A4.9 $60.88 4/30/20216,610,000 shares $529.33 million -9.3%N/A4.7 $80.08 4/15/20217,290,000 shares $556.59 million -14.4%N/A4.8 $76.35 3/31/20218,520,000 shares $615.48 million -2.5%N/A5.2 $72.24 3/15/20218,740,000 shares $572.64 million +8.0%N/A5 $65.52 2/26/20218,090,000 shares $464.93 million -5.6%N/A4.5 $57.47 2/12/20218,570,000 shares $590.64 million -9.3%N/A5.1 $68.92 1/29/20219,450,000 shares $604.52 million -2.3%N/A5.7 $63.97 1/15/20219,670,000 shares $805.51 million -4.7%N/A6.2 $83.30 12/31/202010,150,000 shares $574.29 million -8.1%N/A7.1 $56.58 12/15/202011,040,000 shares $575.18 million -5.6%N/A9 $52.10 11/30/202011,700,000 shares $460.75 million -7.1%N/A10.6 $39.38 11/15/202012,590,000 shares $418.37 million -2.3%N/A13 $33.23 10/30/202012,890,000 shares $321.61 million +0.8%N/A14.4 $24.95 10/15/202012,790,000 shares $316.04 million +7.1%N/A14.7 $24.71 9/30/202011,940,000 shares $237.37 million +7.1%N/A14.8 $19.88 9/15/202011,150,000 shares $248.31 million +2.5%N/A13.9 $22.27 8/31/202010,880,000 shares $234.79 million -0.7%N/A13.8 $21.58 8/14/202010,960,000 shares $217.99 million +1.8%N/A11.8 $19.89Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 7/31/202010,770,000 shares $191.81 million +0.8%N/A10.7 $17.81 7/15/202010,680,000 shares $237.95 million -4.5%26.0%10.8 $22.28 6/30/202011,180,000 shares $228.30 million +11.5%28.0%11.4 $20.42 6/15/202010,030,000 shares $193.98 million -7.2%25.1%10.9 $19.34 5/29/202010,810,000 shares $189.28 million +2.0%24.4%11.5 $17.51 5/15/202010,600,000 shares $187.20 million +2.2%26.5%12.5 $17.66 4/30/202010,370,000 shares $139.68 million -3.5%26.1%13.6 $13.47 4/15/202010,750,000 shares $138.25 million +3.2%27.5%14.2 $12.86 3/31/202010,420,000 shares $151.92 million -2.2%26.6%13.8 $14.58 3/13/202010,656,600 shares $139.07 million +1.3%34.5%10.6 $13.05 2/28/202010,520,000 shares $126.13 million +1.4%34.1%15.5 $11.99 2/14/202010,380,000 shares $142.93 million +1.8%24.8%16.2 $13.77 1/31/202010,200,000 shares $125.46 million +6.8%27.2%15.8 $12.30 1/15/20209,550,000 shares $143.73 million -0.7%25.5%14.8 $15.05 12/31/20199,620,000 shares $132.76 million -3.6%25.7%15.9 $13.80 8/15/20198,571,100 shares $127.45 million -9.4%27.8%15.1 $14.87 NTLA Short Interest - Frequently Asked Questions What is Intellia Therapeutics' current short interest? Short interest is the volume of Intellia Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 15,440,000 shares of NTLA short. Learn More on Intellia Therapeutics' current short interest. What is a good short interest ratio for Intellia Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NTLA shares currently have a short interest ratio of 10.0. Learn More on Intellia Therapeutics's short interest ratio. Which institutional investors are shorting Intellia Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Intellia Therapeutics: Walleye Trading LLC, PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Intellia Therapeutics' short interest increasing or decreasing? Intellia Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 15,440,000 shares, an increase of 5.8% from the previous total of 14,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Intellia Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Intellia Therapeutics: Celldex Therapeutics, Inc. (10.61%), Myriad Genetics, Inc. (6.57%), Neogen Co. (9.26%), QuidelOrtho Co. (4.67%), Editas Medicine, Inc. (24.93%), CRISPR Therapeutics AG (17.18%), Cellectis S.A. (1.18%), Sangamo Therapeutics, Inc. (6.92%), Lantheus Holdings, Inc. (7.14%), Janux Therapeutics, Inc. (9.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Intellia Therapeutics stock? Short selling NTLA is an investing strategy that aims to generate trading profit from Intellia Therapeutics as its price is falling. NTLA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intellia Therapeutics? A short squeeze for Intellia Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NTLA, which in turn drives the price of the stock up even further. How often is Intellia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NTLA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CLDX Short Squeeze MYGN Short Squeeze NEOG Short Squeeze QDEL Short Squeeze EDIT Short Squeeze CRSP Short Squeeze CLLS Short Squeeze SGMO Short Squeeze LNTH Short Squeeze JANX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NTLA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDoes this make you sick?Allegiance GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace